Trials / Completed
CompletedNCT01950533
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 3 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
Food allergy is on the rise within the pediatric population. Having food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Skin prick testing and food-specific IgE testing of the blood can give positive results that are false. Currently, Oral Food Challenges are the best way to diagnose a food allergy. Unfortunately, Oral Food Challenges are time consuming and may not be readily available to suspected food allergy sufferers. This study is designed to examine the effectiveness of an allergy-detecting blood test called IMMULITE 2000 manufactured by the study sponsor, Siemens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Oral food challenge | Confirmation of allergy to egg, milk and/or peanut through an oral food challenge or documentation of a positive oral food challenge. |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2017-03-29
- Completion
- 2017-03-29
- First posted
- 2013-09-25
- Last updated
- 2020-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01950533. Inclusion in this directory is not an endorsement.